Raltegravir (MK-0518)

raltegravir · Merck & Co.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Raltegravir (MK-0518), covering 2012-06-05 to 2012-06-05. Get the full timeline:

Most recent: Clinical Trial Update: Integrase Inhibitor (MK-0518) Viral Decay [Phase 2]